Skip to main content
Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan flag Japan · Delayed Price · Currency is JPY
8,233.00
-239.00 (-2.82%)
At close: Dec 5, 2025

Chugai Pharmaceutical Revenue

Chugai Pharmaceutical had revenue of 333.18B JPY in the quarter ending September 30, 2025, with 5.54% growth. This brings the company's revenue in the last twelve months to 1.21T, up 6.25% year-over-year. In the year 2024, Chugai Pharmaceutical had annual revenue of 1.17T with 5.33% growth.

Revenue (ttm)
1,213.71B
Revenue Growth
+6.25%
P/S Ratio
11.16
Revenue / Employee
241.49M
Employees
5,026
Market Cap
13.55T

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241,170.61B59.24B5.33%
Dec 31, 20231,111.37B-148.58B-11.79%
Dec 31, 20221,259.95B260.19B26.02%
Dec 31, 2021999.76B212.81B27.04%
Dec 31, 2020786.95B100.76B14.68%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
HOYA Corporation 892.50B
Takeda Pharmaceutical Company 4,417.00B
Daiichi Sankyo Company 1,978.88B
Otsuka Holdings 2,418.53B
Terumo 1,062.42B
Astellas Pharma 2,006.82B
Olympus 977.65B
Shionogi & 437.26B
Revenue Rankings

Chugai Pharmaceutical News

More News